Early Icodextrin (ICO) Use Reduced PD-associated Peritonitis Risk

A group of 82 patients who did PD between 2011 and 2020 were divided into a group (n=21) who received ICO at PD initiation and a group (n=61) who received it later or not at all. Patients were followed until they stopped PD, died, or 3 years passed. PD-associated peritonitis and tunnel infection-free survival rates were significantly better with early ICO use.

Read the abstract » | (added 2024-12-11)

Tags: PD, ICO, Early Icodextrin, Peritonitis, Tunnel Infection free Survival Rates